Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Anika Therapeutics (ANIK) over the last 16 years, with Q3 2025 value amounting to $5.5 million.

  • Anika Therapeutics' Other Non-Current Assets fell 5130.86% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 5130.86%. This contributed to the annual value of $5.7 million for FY2024, which is 8442.09% down from last year.
  • Latest data reveals that Anika Therapeutics reported Other Non-Current Assets of $5.5 million as of Q3 2025, which was down 5130.86% from $5.6 million recorded in Q2 2025.
  • Over the past 5 years, Anika Therapeutics' Other Non-Current Assets peaked at $36.3 million during Q4 2023, and registered a low of $5.5 million during Q3 2025.
  • Moreover, its 5-year median value for Other Non-Current Assets was $18.7 million (2021), whereas its average is $17.0 million.
  • As far as peak fluctuations go, Anika Therapeutics' Other Non-Current Assets soared by 11084.27% in 2023, and later plummeted by 8442.09% in 2024.
  • Quarter analysis of 5 years shows Anika Therapeutics' Other Non-Current Assets stood at $20.3 million in 2021, then fell by 15.11% to $17.2 million in 2022, then surged by 110.84% to $36.3 million in 2023, then plummeted by 84.42% to $5.7 million in 2024, then decreased by 2.63% to $5.5 million in 2025.
  • Its Other Non-Current Assets was $5.5 million in Q3 2025, compared to $5.6 million in Q2 2025 and $5.7 million in Q1 2025.